Bor-Shyang Sheu Selected Research

Gastritis

10/2017	Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection.
10/2011	H. pylori cagL amino acid sequence polymorphism Y58E59 induces a corpus shift of gastric integrin α5β1 related with gastric carcinogenesis.
6/2010	Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival.
1/2010	Etiology and treatment of childhood peptic ulcer disease in Taiwan: a single center 9-year experience.
2/2009	Gender difference of circulating ghrelin and leptin concentrations in chronic Helicobacter pylori infection.
9/2004	Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bor-Shyang Sheu Research Topics

Disease

30	Infections 04/2024 - 06/2002
15	Hemorrhage 10/2022 - 11/2003
14	Neoplasms (Cancer) 01/2023 - 07/2002
13	Peptic Ulcer (Peptic Ulcers) 10/2022 - 11/2003
12	Stomach Neoplasms (Stomach Cancer) 06/2022 - 06/2006
12	Metaplasia 06/2022 - 05/2009
9	Inflammation (Inflammations) 10/2017 - 10/2002
8	Ulcer 10/2022 - 09/2009
7	Esophageal Squamous Cell Carcinoma 01/2020 - 01/2014
7	Peptic Esophagitis (Reflux Esophagitis) 01/2012 - 09/2003
6	Gastritis 10/2017 - 09/2004
5	Carcinogenesis 11/2016 - 10/2011
4	Duodenal Ulcer (Curling's Ulcer) 09/2018 - 06/2010
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 06/2016
3	Heartburn (Pyrosis) 01/2020 - 09/2003
3	Adenocarcinoma 09/2018 - 07/2002
3	Hypoalbuminemia 04/2018 - 11/2013
3	Stomach Ulcer (Gastric Ulcer) 01/2012 - 06/2010
2	Gastroesophageal Reflux (GERD) 01/2020 - 09/2014
2	Disease Progression 01/2020 - 09/2005
2	Fibrosis (Cirrhosis) 04/2018 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 10/2017 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2016 - 06/2013
2	Neoplasm Metastasis (Metastasis) 08/2014 - 06/2013
2	Overweight 05/2010 - 11/2007
1	Vomiting 04/2024
1	Dizziness (Lightheadedness) 04/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2021
1	Esophagitis 01/2020
1	Non-Erosive Reflux Disease 01/2020
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 12/2019
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2019
1	Shock 04/2018

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2010
8	Esomeprazole (Nexium)FDA Link 10/2022 - 09/2003
8	Proton Pump InhibitorsIBA 01/2020 - 05/2010
6	Omeprazole (Prilosec)FDA LinkGeneric 11/2013 - 09/2003
5	Matrix Metalloproteinases (MMPs)IBA 06/2013 - 12/2009
4	AcidsIBA 01/2020 - 09/2003
4	Proteins (Proteins, Gene)FDA Link 09/2018 - 07/2002
4	Cytochrome P-450 CYP2C19IBA 01/2012 - 09/2008
3	BismuthIBA 04/2024 - 11/2016
3	Interleukin-8 (Interleukin 8)IBA 01/2022 - 03/2012
3	Metronidazole (Metric)FDA LinkGeneric 11/2020 - 10/2002
3	Clarithromycin (Biaxin)FDA LinkGeneric 11/2020 - 01/2007
3	Immunoglobulin G (IgG)IBA 07/2019 - 03/2005
3	Urea (Carbamide)FDA LinkGeneric 07/2019 - 08/2012
3	spasmolytic polypeptideIBA 06/2019 - 02/2015
3	IntegrinsIBA 01/2019 - 10/2011
3	Amino Acids FDA Link 01/2019 - 10/2011
3	Hemoglobins (Hemoglobin)IBA 04/2018 - 06/2005
3	Indicators and Reagents (Reagents)IBA 04/2018 - 01/2012
3	OsteopontinIBA 07/2017 - 06/2011
3	Pantoprazole (Protonix)FDA LinkGeneric 09/2014 - 05/2010
3	AntralIBA 01/2012 - 09/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2015
2	Peptides (Polypeptides)IBA 06/2022 - 08/2017
2	Lewis Blood Group AntigensIBA 01/2022 - 01/2008
2	AlbuminsIBA 01/2022 - 11/2013
2	Amoxicillin (Wymox)FDA LinkGeneric 11/2020 - 10/2002
2	Levofloxacin (Levaquin)FDA Link 11/2020 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 09/2018 - 02/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2016 - 01/2010
2	EnzymesIBA 06/2013 - 06/2010
2	ImmunosorbentsIBA 06/2013 - 06/2010
2	Celecoxib (Celebrex)FDA Link 04/2013 - 01/2010
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2012 - 08/2010
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2012 - 01/2010
2	N 30IBA 01/2012 - 06/2005
2	TabletsIBA 05/2010 - 11/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2010 - 09/2005
2	beta CateninIBA 01/2010 - 05/2009
1	Parasympatholytics (Antispasmodics)IBA 06/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 11/2020
1	Dexlansoprazole FDA Link 01/2020
1	Hormones (Hormone)IBA 12/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2019
1	Insulin-Like Growth Factor Binding Protein 3IBA 12/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2019
1	MicroRNAs (MicroRNA)IBA 06/2019
1	Blood Group Antigens (Blood Groups)IBA 09/2018
1	Cytotoxins (Cytolysins)IBA 09/2018
1	Type IV Secretion SystemsIBA 09/2018
1	Serum AlbuminIBA 04/2018
1	Insulin (Novolin)FDA Link 10/2017

Therapy/Procedure

21	Therapeutics 04/2024 - 06/2002
5	Endoscopic Hemostasis 01/2020 - 09/2009
3	Chemoradiotherapy 01/2020 - 03/2015
2	Gastrectomy 01/2021 - 06/2002
1	Length of Stay 01/2021
1	Nutritional Support (Artificial Feeding) 01/2021
1	Radiotherapy 01/2020
1	Glycemic Control 07/2019
1	Intravenous Infusions 04/2018